CHM 0.00% 1.4¢ chimeric therapeutics limited

Ann: Successful Completion of First Patient Cohort Phase 1 Trial, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 172 Posts.
    lightbulb Created with Sketch. 90
    Great result (as expected for the safety trial). Onwards and upwards. Bring on Phase II.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.